Chios Mastic Gum: Chemical Profile and Pharmacological Properties in Inflammatory Bowel Disease: From the Past to the Future

Int J Mol Sci. 2023 Jul 27;24(15):12038. doi: 10.3390/ijms241512038.

Abstract

Chios mastic gum, the product of the tree Pistacia lentiscus var. Chia, has been used for more than 2500 years in traditional Greek medicine for treating several diseases, thanks to the anti-inflammatory and antioxidant properties of its components. Despite the long-time use of mastic in gastroenterology and in particular in chronic-inflammation-associated diseases, to date, the literature lacks reviews regarding this topic. The aim of the present work is to summarize available data on the effects of P. lentiscus on inflammatory bowel disease. A comprehensive review of this topic could drive researchers to conduct future studies aimed at deeply investigating P. lentiscus effects and hypothesizing a mechanism of action. The present review, indeed, schematizes the possible bioactive components of mastic gum. Particular care is given to P. lentiscus var. Chia medicaments' and supplements' chemical compositions and their pharmacological action in inflammatory bowel disease.

Keywords: Chios mastic gum; IBD; Pistacia lentiscus var. Chia; chemical profile; inflammatory bowel disease; phytochemistry.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy
  • Mastic Resin
  • Pistacia* / chemistry
  • Resins, Plant / chemistry
  • Resins, Plant / pharmacology
  • Resins, Plant / therapeutic use

Substances

  • Mastic Resin
  • Resins, Plant
  • Antioxidants
  • Anti-Inflammatory Agents

Grants and funding

This work is supported by grants from Università degli Studi di Milano, Finanziamento di Ateneo Linea 2, with funding to P.C. and G.M., and APC initiative to O.X.